Phase III trial of JDP 205 intravenous injection for the treatment of urticaria associated with an allergic reaction

Trial Profile

Phase III trial of JDP 205 intravenous injection for the treatment of urticaria associated with an allergic reaction

Planning
Phase of Trial: Phase III

Latest Information Update: 08 Jan 2015

At a glance

  • Drugs Cetirizine (Primary)
  • Indications Hypersensitivity; Urticaria
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 08 Jan 2015 The initial phase III trial has been completed and JDP Therapeutics is working with the US FDA on the design of this larger phase III trial, according to a company media release.
    • 03 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top